PYC Therapeutics is a development-stage biotechnology company pioneering a new generation of RNA therapeutics that utilize Cell Penetrating Peptides (CPPs), a revolutionary delivery technology designed to overcome the major challenges of current gene-based therapies.

Biotechnology

PYC Therapeutics

Garrett Bray

Paula Cunningham

Rohan Hockings

The Research and Development team at PYC Therapeutics is dedicated to advancing innovative RNA therapeutic solutions using Cell Penetrating Peptides (CPPs). This team, comprised of leading scientific experts, collaborates on designing and optimizing therapeutic candidates, conducting preclinical studies, and ensuring regulatory compliance to bring cutting-edge gene-based therapies from concept to reality.

Research and Development

About

Team members

Other teams at PYC Therapeutics

Research and Development

Research and Development